• Synergistic Inhibition of eIF4F, AKT1, and EZH2 in BRAFV600E

  2026-05-15

  This study demonstrates that combined inhibition of the eIF4F complex, AKT1, and EZH2 overcomes resistance in BRAFV600E mutant melanoma cells, enhancing the efficacy of both eIF4F and BRAF-targeted therapies. The findings advance understanding of adaptive resistance mechanisms and offer a rationale for multi-target therapeutic strategies in melanoma.

• Modeling HSV-1 Latency in Human iPSC-Derived Sensory Neurons

  2026-05-15

  This study establishes a reproducible platform for differentiating human inducible pluripotent stem cells (hiPSCs) into sensory neurons, enabling robust modeling of latent and reactivatable herpes simplex virus 1 (HSV-1) infection. The work addresses a key translational gap by providing a human neuron-based system previously limited to animal models, offering new opportunities for mechanistic and therapeutic HSV-1 latency research.

• Adipose-Neural Axis Drives Arrhythmia via Leptin-NPY Pathway

  2026-05-14

  Fan et al. (2024) develop a stem cell-based coculture model to reveal how the adipose-neural axis, via leptin-induced neuropeptide Y (NPY) signaling, contributes to epicardial adipose tissue-related cardiac arrhythmias. This mechanistic insight identifies new molecular targets—specifically leptin, NPY/Y1R, NCX, and CaMKII—for potential arrhythmia interventions.

• Ambroxol Modulation of Nav1.8, TRPV1, and TRPA1 in Neuropath

  2026-05-14

  This study provides mechanistic insight into how ambroxol modulates human Nav1.8 sodium channels and irritant receptors TRPV1 and TRPA1, key targets in topical neuropathic pain management. The findings clarify ambroxol's species-specific effects and its interaction with capsaicin-induced TRPV1 activity, informing future strategies for targeted analgesia.

• AMPK Inhibits Autophagy Initiation Under Glucose Starvation

  2026-05-13

  This study fundamentally revises our understanding of cellular energy stress responses by showing that AMPK, contrary to longstanding models, suppresses rather than activates autophagy initiation during glucose deprivation. These findings clarify the nuanced regulation of metabolic signaling and have significant implications for designing experiments investigating autophagy and energy homeostasis.

• Discovery of MK 0893: A Potent Glucagon Receptor Antagonist

  2026-05-13

  The reference study reports the discovery and characterization of MK 0893, a highly potent, selective, and orally bioavailable glucagon receptor antagonist. By optimizing lead structures for improved potency and selectivity, the authors demonstrate robust in vitro and in vivo efficacy in models of type 2 diabetes, supporting MK 0893 as a critical tool for translational metabolic research.

• Isolation and Characterization of Baicalin Methyl Ester from

  2026-05-12

  The reference study by Ishimaru et al. provides a rigorous structural characterization of baicalin methyl ester (BME) and related flavonoids from Scutellaria baicalensis roots, using advanced chromatographic and spectroscopic methods. This foundational work underpins ongoing research exploring BME's mechanisms in intestinal barrier protection and anti-inflammatory signaling.

• BFH772 (VEGFR2 inhibitor): Technical Guidance & Protocols

  2026-05-12

  BFH772 (VEGFR2 inhibitor) is a highly selective small molecule designed for precise inhibition of VEGFR2-mediated angiogenesis, mainly in tumor model research. It should be used in workflows requiring high kinase selectivity and compatibility with organic solvents, not in protocols demanding water solubility or broad-spectrum kinase inhibition.

• Imipenem in Immune Modulation: Advanced Pathways & Research

  2026-05-11

  Explore how Imipenem, a semisynthetic thienamycin antibiotic, uniquely shapes immune response and experimental sepsis outcomes. This article delivers new insights for antibacterial research by connecting molecular action, in vitro immunomodulation, and translational animal models.

• AMPK Regulates Mitophagy and Inflammation in Diabetic Period

  2026-05-11

  This study establishes AMPK as a central regulator coordinating PINK1/Parkin-mediated mitophagy and NLRP3-driven inflammation in periodontal ligament fibroblasts under mechanical loading, especially in diabetic conditions. The findings reveal that targeted AMPK activation restores mitophagic flux and attenuates inflammatory responses, providing mechanistic insights into tissue homeostasis and suggesting new therapeutic avenues for diabetic periodontal disease.

• CBD Modulates Endocannabinoid Signaling in Orofacial Pain Mo

  2026-05-10

  This study demonstrates that cannabidiol (CBD) alleviates both sensory and affective aspects of orofacial inflammatory pain in mice by modulating central and peripheral endocannabinoid pathways. The findings reveal CBD's multi-level action—downregulating FAAH, elevating anandamide, and normalizing serotonergic signaling—highlighting new translational avenues for comprehensive pain management.

• Cardiogreen (Indocyanine Green): Precision in Diagnostics &

  2026-05-09

  Cardiogreen (Indocyanine Green) stands out for its dual role in high-fidelity vascular diagnostics and apoptosis-driven photodynamic therapy. Its robust workflow compatibility and reproducible results make it the choice for researchers seeking reliable cardiac output measurement and innovative cancer treatment strategies.

• Amikacin (BAY416651): Applied Workflows for Resistance Resea

  2026-05-09

  Amikacin (BAY416651) stands out as a robust bacterial protein synthesis inhibitor, uniquely suited for dissecting multidrug resistance in Enterobacter cloacae and Klebsiella pneumoniae. This guide translates recent reference breakthroughs into actionable, reproducible experimental strategies—optimizing both workflow integrity and troubleshooting for antibiotic resistance research.

• Spermine: Endogenous Polyamine for Advanced Ion Channel Rese

  2026-05-08

  Spermine empowers researchers with precise, high-purity polyamine modulation for reliable inward rectifier potassium channel studies and cellular metabolism assays. Its robust solubility, validated blocking mechanisms, and proven protocol versatility set it apart for neurophysiology and emerging virology workflows.

• Hierarchical Nanoparticle-Hydrogel Platform Repairs Macropha

  2026-05-07

  This study introduces a hierarchically targeted, ROS-responsive nanoparticle-hydrogel platform that disrupts the mitochondrial ROS-inflammation loop in M1 macrophages, central to diabetic periodontitis pathology. By achieving mitochondrial repair and local anti-inflammatory drug delivery, the platform significantly enhances tissue regeneration and offers a translational advance beyond current periodontal therapies.

450 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page